The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Roberts Eiry since 2019.
This trader's CIK number is 1727606.
At the time of last reporting, Roberts Eiry was the Chief Medical Officer of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NBIX | 0 | $0 | 3,198 | $374,073 | 6,465 | $0 |
| 2024 | NBIX | 0 | $0 | 4,672 | $644,220 | 7,345 | $625,757 |
| 2023 | NBIX | 0 | $0 | 145,580 | $16,991,845 | 100,000 | $7,913,210 |
| 2022 | NBIX | 0 | $0 | 6,356 | $495,684 | 0 | $0 |
| 2021 | NBIX | 0 | $0 | 4,995 | $568,171 | 0 | $0 |
| 2020 | NBIX | 0 | $0 | 15,703 | $1,775,530 | 5,000 | $389,050 |
| 2019 | NBIX | 0 | $0 | 1,857 | $156,158 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-14 | NBIX | Sale | 500 | 115.04 | 57,521 |
| 2025-02-13 | NBIX | Option Ex | 4,605 | .00 | 0 |
| 2025-02-13 | NBIX | Sale | 1,718 | 116.82 | 200,700 |
| 2025-02-08 | NBIX | Option Ex | 1,860 | .00 | 0 |
| 2025-02-10 | NBIX | Sale | 980 | 118.22 | 115,852 |
| 2024-11-08 | NBIX | Option Ex | 7,345 | 85.19 | 625,757 |
| 2024-02-13 | NBIX | Sale | 1,114 | 132.96 | 148,121 |
| 2024-02-06 | NBIX | Sale | 1,121 | 142.24 | 159,446 |
| 2024-02-08 | NBIX | Sale | 980 | 134.21 | 131,521 |
| 2024-01-31 | NBIX | Sale | 1,457 | 140.79 | 205,132 |
| 2023-12-22 | NBIX | Sale | 10,000 | 126.75 | 1,267,450 |
| 2023-12-12 | NBIX | Option Ex | 13,925 | 81.05 | 1,128,621 |
| 2023-12-12 | NBIX | Sale | 13,925 | 120.31 | 1,675,247 |
| 2023-12-07 | NBIX | Option Ex | 77,379 | 78.92 | 6,106,982 |
| 2023-12-08 | NBIX | Option Ex | 300 | 81.05 | 24,315 |
| 2023-12-07 | NBIX | Sale | 77,379 | 120.37 | 9,314,264 |
| 2023-12-08 | NBIX | Sale | 300 | 120.08 | 36,023 |
| 2023-12-06 | NBIX | Option Ex | 8,396 | 77.81 | 653,292 |
| 2023-12-06 | NBIX | Sale | 8,396 | 120.03 | 1,007,780 |
| 2023-08-21 | NBIX | Sale | 3,198 | 107.38 | 343,388 |
| 2023-04-24 | NBIX | Sale | 14,400 | 103.48 | 1,490,054 |
| 2023-02-07 | NBIX | Sale | 14,424 | 102.38 | 1,476,714 |
| 2023-02-08 | NBIX | Sale | 980 | 104.16 | 102,071 |
| 2023-02-06 | NBIX | Sale | 1,121 | 105.80 | 118,601 |
| 2023-01-31 | NBIX | Sale | 1,457 | 109.99 | 160,253 |
| 2022-02-07 | NBIX | Sale | 2,744 | 80.78 | 221,668 |
| 2022-02-08 | NBIX | Sale | 980 | 79.52 | 77,930 |
| 2022-01-10 | NBIX | Sale | 2,632 | 74.50 | 196,086 |
| 2021-02-08 | NBIX | Sale | 2,363 | 116.75 | 275,875 |
| 2021-01-08 | NBIX | Sale | 2,632 | 111.06 | 292,296 |
| 2020-11-12 | NBIX | Sale | 2,257 | 90.74 | 204,809 |
| 2020-08-05 | NBIX | Sale | 2,257 | 118.84 | 268,226 |
| 2020-06-23 | NBIX | Sale | 5,000 | 130.00 | 650,000 |
| 2020-06-23 | NBIX | Option Ex | 5,000 | 77.81 | 389,050 |
| 2020-04-24 | NBIX | Sale | 1,934 | 99.47 | 192,376 |
| 2020-02-07 | NBIX | Sale | 1,623 | 103.31 | 167,675 |
| 2020-01-08 | NBIX | Sale | 2,632 | 111.11 | 292,444 |
| 2019-01-08 | NBIX | Sale | 1,857 | 84.09 | 156,158 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roberts Eiry (Chief Medical Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.